P-409 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023

A. Esmail, J. Xu, E. Burns, K. Gee, C. Wiechmann, Y. Zhang, R. Kieser, Z. Gong, G. Umoru, S. Shah, K. Sun, K. Heyne, M. Abdelrahim

Research output: Contribution to journalArticlepeer-review

Cite this